DocWire News Editors

DocwireNews

For patients with chronic kidney disease (CKD), multidisciplinary education can play a role in prevention of disease progression and development of end-stage renal disease (ESRD). Researchers in Japan conducted a study to examine the relationship between estimated glomerular filtration rate (eGFR) slopes before and after CKD education and disease progression.The retrospective cohort study included 617 patients who underwent in-hospital CKD education at the Nara Prefecture General Medical Center, Nara, Nara, Japan, between January 2013 and December 2016. Following exclusion for the presence of acute kidney injury, urologic malignancies, or collagen disease, the final analysis included 194 patients.The researchers calculated two eGFR slopes before and after the education intervention with three eGFR levels measured at 3 months to 1 year prior to the intervention, at baseline, and at least 1 year after the intervention. The slope categories were divided according to median levels of two eGFR slopes before and after the education intervention. Slope categories were defined as slow-slow, fast-slow, slow-fast, and fast-fast eGFR decliner. The study outcomes of interest were ESRD and eGFR decline of &ge;30%. The reference group was the group with fast-slow eGFR declines.Median age of the final cohort was 68 years and 67% (n=130) were male. At baseline, median eGFR was 33 mL/min/1.73 m2 (range, 21-48 mL/min/1.73 m2). Median follow-up was 35 months. During follow-up, 53 participants experienced a renal event. In crude Kaplan-Meier analysis, there was a significant association of slow-fast and fast-fast eGFR declines and renal events (P&lt;0.001).Results of adjusted Cox hazards analyses found hazard ratios for outcomes were 1.72 (95% CI, 0.38-8.8) for slow-slow eGFR decliners, 5.15 (95% CI, 1.72-22.2) for slow-fast eGFR decliners, and 7.27 (95% CI, 2.53-30.7) for fast-fast eGFR decliners.The researchers said, &ldquo;Improvement from fast to slow eGFR decline via CKD education was significantly associated with better renal prognosis. However, CKD patients with rapid eGFR decline of &ndash;2.5 or more mL/min/1.73 m2 after the education intervention have poor renal outcomes.&rdquo;<a href="https://www.asn-online.org/education/kidneyweek/2019/program-abstract.aspx?controlId=3222608">Read more here</a>Source: Uemura T, Matsui M, Kokubu M, Tsuruya K. Association of eGFR slopes before and after CKD education with renal prognosis. Abstract of a poster presented at the American Society of Nephrology Kidney Week 2019 (Abstract FR-PO324), November 8, 2019, Washington, DC.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

CKD Education Improves eGFR Slopes

ASN Kidney Week 2019

For patients with chronic kidney disease (CKD), multidisciplinary education can play a role in prevention of disease progression and development of end-stage renal disease ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe